Lin Mu

575 total citations
22 papers, 420 citations indexed

About

Lin Mu is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Lin Mu has authored 22 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Nephrology and 7 papers in Surgery. Recurrent topics in Lin Mu's work include Renal Diseases and Glomerulopathies (5 papers), Chronic Kidney Disease and Diabetes (4 papers) and Cholesterol and Lipid Metabolism (4 papers). Lin Mu is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Chronic Kidney Disease and Diabetes (4 papers) and Cholesterol and Lipid Metabolism (4 papers). Lin Mu collaborates with scholars based in China and Hong Kong. Lin Mu's co-authors include Zhifen Yang, Shan Song, Ming Wu, Chunyang Du, Yonghong Shi, Chengyu Zhang, Yu Shi, Nan Chen, Shaomei Li and Huijun Duan and has published in prestigious journals such as Journal of Hazardous Materials, Frontiers in Immunology and Advanced Science.

In The Last Decade

Lin Mu

20 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Mu China 10 211 137 68 61 60 22 420
Jinfei Yang China 13 206 1.0× 105 0.8× 50 0.7× 109 1.8× 35 0.6× 26 462
Mian Wu China 11 162 0.8× 198 1.4× 54 0.8× 68 1.1× 24 0.4× 26 402
Chao Yu China 13 265 1.3× 123 0.9× 60 0.9× 44 0.7× 34 0.6× 39 490
Yibo Zhuang China 10 232 1.1× 115 0.8× 82 1.2× 30 0.5× 54 0.9× 15 396
Farah Lizotte Canada 11 178 0.8× 124 0.9× 88 1.3× 42 0.7× 46 0.8× 22 427
Rongguo Fu China 11 158 0.7× 60 0.4× 72 1.1× 70 1.1× 58 1.0× 24 378
Sun Ha Lee South Korea 11 155 0.7× 159 1.2× 62 0.9× 22 0.4× 55 0.9× 16 406
Suyan Duan China 12 204 1.0× 209 1.5× 47 0.7× 114 1.9× 25 0.4× 38 527
Xingchen Zhao China 13 201 1.0× 178 1.3× 50 0.7× 118 1.9× 35 0.6× 26 470
Mercedes Muros‐de‐Fuentes Spain 7 122 0.6× 246 1.8× 54 0.8× 37 0.6× 41 0.7× 10 439

Countries citing papers authored by Lin Mu

Since Specialization
Citations

This map shows the geographic impact of Lin Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Mu more than expected).

Fields of papers citing papers by Lin Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Mu. The network helps show where Lin Mu may publish in the future.

Co-authorship network of co-authors of Lin Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Mu. A scholar is included among the top collaborators of Lin Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Mu. Lin Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Chunyang, Yan Zhu, Yan Yang, et al.. (2025). A-485 alleviates fibrosis and apoptosis in kidney by disrupting tandem activation of acetylation and phosphorylation on STAT3. Biomedicine & Pharmacotherapy. 188. 118217–118217.
2.
Gao, Qiang, Min Xu, Lin Mu, et al.. (2025). Microplastics and nanoplastics increase major adverse cardiac events in patients with myocardial infarction. Journal of Hazardous Materials. 489. 137624–137624. 18 indexed citations
3.
4.
Yang, Yakun, et al.. (2025). Comprehensive bioinformatics and in vivo validation reveal key molecular drivers of diabetic nephropathy progression. Frontiers in Endocrinology. 16. 1654401–1654401.
5.
Mu, Lin, et al.. (2024). Comprehensive analysis of juvenile idiopathic arthritis patients’ immune characteristics based on bulk and single-cell sequencing data. Frontiers in Molecular Biosciences. 11. 1359235–1359235. 1 indexed citations
6.
Zhang, Shuyan, Jiajun Wu, Leilei Wang, et al.. (2024). SIRT1/P53 in retinal pigment epithelial cells in diabetic retinopathy: a gene co-expression analysis and He-Ying-Qing-Re formula treatment. Frontiers in Molecular Biosciences. 11. 1366020–1366020. 5 indexed citations
7.
Zhou, Huandi, Lin Mu, Zhifen Yang, & Yonghong Shi. (2023). Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy. Frontiers in Immunology. 14. 1113212–1113212. 9 indexed citations
8.
Mu, Lin, et al.. (2022). Blocking REDD1/TXNIP Complex Ameliorates HG-Induced Renal Tubular Epithelial Cell Apoptosis and EMT through Repressing Oxidative Stress. International Journal of Endocrinology. 2022. 1–15. 9 indexed citations
9.
Zhou, Huandi, Zhifen Yang, Lin Mu, & Yonghong Shi. (2022). Integrated Analysis of Multiple Microarray Studies to Identify Core Gene‐Expression Signatures Involved in Tubulointerstitial Injury in Diabetic Nephropathy. BioMed Research International. 2022(1). 9554658–9554658. 6 indexed citations
10.
Du, Chunyang, Yan Zhu, Yan Yang, et al.. (2022). C1q/tumour necrosis factor-related protein-3 alleviates high-glucose-induced lipid accumulation and necroinflammation in renal tubular cells by activating the adenosine monophosphate-activated protein kinase pathway. The International Journal of Biochemistry & Cell Biology. 149. 106247–106247. 3 indexed citations
11.
Song, Shan, et al.. (2022). Sestrin2 remedies podocyte injury via orchestrating TSP-1/TGF-β1/Smad3 axis in diabetic kidney disease. Cell Death and Disease. 13(7). 663–663. 39 indexed citations
12.
Song, Shan, Lin Mu, Ming Wu, et al.. (2022). Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy. Cell and Tissue Research. 390(1). 93–112. 18 indexed citations
13.
Chen, Nan, et al.. (2022). ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease.. PubMed. 33(169). 69–83. 7 indexed citations
14.
Chen, Nan, Shan Song, Zhifen Yang, et al.. (2021). ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy. Journal of Diabetes and its Complications. 35(12). 108050–108050. 12 indexed citations
15.
Wu, Ming, Zhifen Yang, Chengyu Zhang, et al.. (2021). Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Metabolism. 118. 154748–154748. 139 indexed citations
16.
Li, Xin, Lijie Zhang, Yongsong Xu, et al.. (2021). Therapeutic Effect of Matrine on Collagen-Induced Arthritis Rats and Its Regulatory Effect on RANKL and OPG Expression. Journal of Immunology Research. 2021. 1–9. 10 indexed citations
17.
Chen, Nan, Lin Mu, Zhifen Yang, et al.. (2020). Carbohydrate response element‐binding protein regulates lipid metabolism via mTOR complex1 in diabetic nephropathy. Journal of Cellular Physiology. 236(1). 625–640. 44 indexed citations
18.
Wang, Yuan, et al.. (2020). The anti-inflammatory properties of HDLs are impaired in gout. Clinical Rheumatology. 40(4). 1525–1531. 6 indexed citations
19.
Mu, Lin, et al.. (2019). Rhein alleviates renal interstitial fibrosis by inhibiting tubular cell apoptosis in rats. Biological Research. 52(1). 50–50. 37 indexed citations
20.
Wang, Chen, Zhifen Yang, Lin Mu, et al.. (2019). SRT1720 retards renal fibrosis via inhibition of HIF1A/GLUT1 in diabetic nephropathy. Journal of Endocrinology. 241(1). 85–98. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinfei Yang Breakdown of academic impact, for papers by Mian Wu Breakdown of academic impact, for papers by Chao Yu Breakdown of academic impact, for papers by Yibo Zhuang Breakdown of academic impact, for papers by Farah Lizotte Breakdown of academic impact, for papers by Rongguo Fu Breakdown of academic impact, for papers by Sun Ha Lee Breakdown of academic impact, for papers by Suyan Duan Breakdown of academic impact, for papers by Xingchen Zhao Breakdown of academic impact, for papers by Mercedes Muros‐de‐Fuentes
Rankless by CCL
2026